Higher Uric Acid in Inpatient COVID-19 Cases Ups AKI Risk
Patients with COVID-19 who had the highest quartile of serum uric acid at hospital admission had increased odds of acute kidney injury.
Patients with COVID-19 who had the highest quartile of serum uric acid at hospital admission had increased odds of acute kidney injury.
New analysis suggests that gout prevalence is 21% among patients on peritoneal dialysis and 13% among those on hemodialysis.
New findings complement previous research showing no renoprotective effect of urate-lowering therapy in patients with chronic kidney disease.
In a study of kidney transplant recipients treated with pegloticase for uncontrolled gout, the proportion of patients experiencing gout flares declined over the treatment period.
Some 15% of patients receiving dialysis in the United States have a gout diagnosis, according to a recent study.
Although previous studies have observed that Black patients are less likely to receive kidney transplants than White patients, the points of inequity in the transplant process were unclear.
The novel intravenous calcimimetic might cause fewer gastrointestinal symptoms, new research suggests.
In the BETonMACE trial, CKD patients with type 2 diabetes who recently experienced acute coronary syndrome who received apabetalone had a significant 50% reduction in the risk for major cardiovascular events compared with placebo.
Difelikefalin, an investigational intravenous drug, improved moderate to severe itching compared with placebo in patients on hemodialysis, according to phase 3 trial results.
Finerenone vs placebo added to standard therapy was associated with a significant 18% reduction in the risk for major adverse kidney events in patients with both chronic kidney disease and type 2 diabetes mellitus.